Sponsored Links

Featured Links

Other Topics
Sponsored Links







Quote of the Day

"Always vote for principle, though you may vote alone, and you may cherish the sweetest reflection that your vote is never lost."

John Quincy Adams






Click here for eBay Motors!


 






 
Featured Arthritis Articles

Arthritis Relief
Arthritis is a big issue. Look at some introductory facts. Referred to as the nation's number one crippling disease and the most common chronic disease in people over 40, arthritis affects more than 40 million Americans. And this figure is expected to ...

Arthritis Symptom
Arthritis Symptom FactIt is not uncommon to hear of people talking about joint pain and stiffness when the weather changes, this is in fact an arthritis symptom that most people suffer from with this disease. Many different things can bring out an ...

A Medication Guide for Arthritis Patients: Do's and Don'ts
Arthritis patients require relief from their pain. They also require direction when it comes to medications.Since these patients are often seen by multiple physicians, clear and direct information about how to manage their medications is important.Here ...




Doctor... What's the Best Treatment for Arthritis?
 

Regardless of the type of arthritis, the goals of arthritis treatment are similar.

These include the following:

• Relieve pain/inflammation
• Minimize risks of therapy
• Retard disease progression
• Provide patient education
• Prevent work disability
• Enhance quality of life and functional independence

While the goals are similar they are achieved using different approaches depending on the diagnosis. The effective management includes a combination of conventional medicines, effective alternative treatments, changes in diet and food, rest, exercise, lifestyle changes (e.g., weight loss if needed), and joint protection.

Factors involved in decision making include the diagnosis, the severity of disease, and the patient’s response to previous therapies.

The decision making doesn’t end there either. As a patient is followed over time, things change. What initially was felt to be an effective arthritis treatment may no longer be effective...and side-effects may occur.

Additions and deletions of medications need to be considered. Drug interactions with other therapies are a concern.

Co-morbid conditions (other medical illnesses) enter into the equation. Newer therapies, when they arrive, may change the picture.

Patient preference, when it can be accommodated, should also be considered. And this dovetails with a patient’s lifestyle... The right therapy for a working man of 35 may not be the right therapy for a retired woman of 80. The correct arthritis treatment for a hard-driving executive may not be ideal for a laid back person who wants to use as many natural remedies as possible.

Finally, the ever-changing landscape of insurance issues plays a role... in my opinion, way too big a role in decision making. In fact, I feel patients should not- not ever- make a decision to see a rheumatologist based on whether the physician “participates in their insurance plan” or not. The reason is that insurance plans do not pay a good physician what they are worth. If you value your health enough to get better, to feel less pain, to avoid crippling, then you owe it to yourself to see the best specialist, not the cheapest, and not just the one who “participates in your insurance plan.”

Dr. Wei (pronounced “way”) is a board-certified rheumatologist and Clinical Director of the nationally respected Arthritis and Osteoporosis Center of Maryland. He is a Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine and has served as a consultant to the Arthritis Branch of the National Institutes of Health. He is a Fellow of the American College of Rheumatology and the American College of Physicians. For more information on arthritis and related conditions, go to: http://www.arthritis-treatment-and-relief.com



Written By: Nathan Wei


Google


Arthritis News

Synta and Roche Form Discovery, Development, and Commercialization ... - Genetic Engineering News
Synta Pharmaceuticals Corp. ( NASDAQ: SNTA ) and Roche (SWX: ROG) announced today the formation of a strategic alliance to discover, develop, and commercialize small-molecule drugs targeting a novel family of ion channels that are critical to immune ...

Velcura to Begin Clinical Trials For Arthritis Drug - WWJ Newsradio 950
Ann Arbor-based Velcura Therapeutics Inc. said Wednesday that it had completed its second successful Investigational New Drug application to the United States Food and Drug Administration for its lead compound, VEL-0230. The November 2008 IND filing ...

Start-up testing gene-based treatment for arthritis - Tech Journal South
CHAPEL HILL, NC—Attorney Sheila Mikhail is once again showing that raising venture money is not the only way to get a promising start up going, even in the money-hungry field of biotech. Not only that, sometimes, all that’s necessary to improve ...

CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of ... - MSN MoneyCentral
VIENNA, Va. , Jan. 7 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Alternext US : CVM ) announced today the initiation of a definitive study of its new rheumatoid arthritis treatment vaccine (CEL-2000) to determine the long-lasting beneficial ...

Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid ... - Phramalive.com
ANN ARBOR, Mich. January 07, 2009 /PRNewswire/ -- Velcura Therapeutics Inc., a clinical-phase biotechnology company developing therapies for bone disease, has completed its second successful Investigational New Drug application (IND) to the U.S. Food ...